"The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE EMAGINE STUDY)"

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 4, 2021

Primary Completion Date

November 6, 2023

Study Completion Date

January 16, 2024

Conditions
Ischemic Stroke
Interventions
DEVICE

BQ 2.0

frequency and intensity parameters will be set to zero so that no stimulation is delivered

DEVICE

BQ 2.0

The BQ 2.0 is a medical device that produces and delivers non-invasive, extremely low intensity and frequency (1-100 Hz.; up to 1 G), frequency tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery

Trial Locations (15)

11215

NYP Brooklyn Methodist Hospital Outpatient Rehabilitation, Brooklyn

19027

Moss Rehabilitation Research Institute, Elkins Park

20010

MedStar National Rehabililtaion Hospital,, Washington D.C.

28203

Atrium Health Carolinas Rehabilitation, Charlotte

32216

Brooks Rehabilitation Hospital - University Campus, Jacksonville

33136

The Miami Project to Cure Paralysis, Miami

60611

Shirley Ryan Abilitylab, Chicago

66160

KU Medical Center, Kansas City

75246

Baylor Scott & White Institute for Rehabilitation, Dallas

77030

TIRR Memorial Hermann Hospital, Houston

90095

Ronald Reagan UCLA Medical Center & California Rehabilitation Institute, Los Angeles

90242

Rancho Research Institute, Downey

02129

Spaulding Rehabilitation Hospital, Boston

08820

JFK Johnson Rehabilitation Institute, Edison

07052

Kessler Institute of Rehabilitation, West Orange

Sponsors
All Listed Sponsors
lead

BrainQ Technologies Ltd.

INDUSTRY

NCT05044507 - "The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE EMAGINE STUDY)" | Biotech Hunter | Biotech Hunter